Zhaoke (Hong Kong) Ophthalmology Pharmaceutical Ltd.
- Biotech or pharma, therapeutic R&D
Zhaoke Ophthalmology Limited (SEHK: 6622) is a leading ophthalmic pharmaceutical company focused on developing, manufacturing, and commercializing therapies for major eye diseases. Their pipeline includes treatments for dry eye disease (DED), wet age-related macular degeneration, diabetic macular edema, myopia, presbyopia, and glaucoma.
Zhaoke Ophthalmology seeks global out-licensing partners to expand its market reach. Recent partnerships include AFT Pharmaceuticals for Australia and New Zealand, Kwangdong Pharmaceutical for South Korea, Lunatus for Middle East, and InterPharma for Thailand.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}